Skip to main content

Want a detailed portfolio tracker?

Jupiter Neurosciences (JUNS) P/E (2024 - 2026)

Jupiter Neurosciences (JUNS) P/E from Dec 3, 2024 to Jul 21, 2026. The TTM Jupiter Neurosciences (JUNS) P/E is -0.65. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Jupiter Neurosciences (JUNS)

YearP/EChange
2026-0.65-84.03%
2025-4.04-97.04%
2024-136.66N/A

Comparison Jupiter Neurosciences (JUNS) P/E with competitors

Jupiter Neurosciences (JUNS) P/E is -0.65.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.26%
NBYStablecoin Development Corp0.00-100.67%
ENLVEnlivex Ltd0.07-111.59%
FGENFibroGen Inc0.24-137.21%
CHRSCoherus Biosciences Inc0.85-231.52%
FBIOFortress Biotech Inc0.95-247.10%
ORMPOramed Pharmaceuticals Inc1.50-332.97%
AGENAgenus Inc3.01-566.49%
INVAInnoviva Inc3.15-588.87%
VXRTVaxart Inc3.55-650.21%
CRMDCorMedix Inc3.63-662.41%
CVACCureVac N.V.4.45-789.08%
GLPGGalapagos NV4.86-853.13%
SRPTSarepta Therapeutics Inc4.88-856.72%
ABEOAbeona Therapeutics Inc5.39-935.07%
ABUSArbutus Biopharma Corp5.60-967.32%
ZVRAZevra Therapeutics Inc5.89-1012.52%
SPROSpero Therapeutics Inc6.23-1065.41%
CGENCompugen Ltd6.31-1078.66%
RIGLRigel Pharmaceuticals6.87-1165.17%
SLXNSilexion Therapeutics Corp7.30-1230.89%
OMEROmeros Corporation9.26-1535.11%
AUPHAurinia Pharmaceuticals Inc9.58-1585.67%
PLXProtalix BioTherapeutics Inc10.89-1788.11%
ACADAcadia Pharmaceuticals Inc11.73-1917.93%
TBPHTheravance Biopharma Inc12.26-2000.64%
ADMAAdma Biologics Inc12.42-2024.82%
HRMYHarmony Biosciences Holdings Inc13.82-2242.14%
SABSSAB Biotherapeutics Inc14.14-2291.12%
NAGENiagen Bioscience Inc14.82-2396.82%
INCYIncyte Corp15.82-2552.51%
REGNRegeneron Pharmaceuticals Inc15.86-2557.79%
PBYIPuma Biotechnology Inc17.32-2783.95%
CPRXCatalyst Pharmaceuticals Inc17.44-2803.11%
EXELExelixis Inc17.54-2818.41%
TGTXTG Therapeutics Inc18.97-3039.76%
MDXGMimedx Group Inc20.55-3285.66%
XOMAXOMA Royalty Corp22.87-3645.69%
ARGXArgen X SE24.30-3866.31%
CTMXCytomX Therapeutics Inc24.82-3947.39%
XOMAOXOMA Royalty Corp25.34-4028.57%
HALOHalozyme Therapeutics Inc25.62-4071.80%
XOMAPXOMA Royalty Corp25.67-4078.99%
VRTXVertex Pharmaceuticals Inc27.99-4439.32%
RPRXRoyalty Pharma plc - Class A28.69-4546.71%
SLNOSoleno Therapeutics Inc29.02-4597.52%
ASNDAscendis Pharma A/S30.09-4763.41%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5976.55%
APLSApellis Pharmaceuticals Inc39.02-6148.48%
BMRNBiomarin Pharmaceutical Inc42.21-6643.05%
KRYSKrystal Biotech Inc45.34-7128.46%
ONCBeiGene Ltd69.54-10879.12%
PHARPharming Group N.V.75.03-11729.34%
TECHBio-Techne Corp101.96-15904.06%
VCELVericel Corp109.92-17138.36%
ALNYAlnylam Pharmaceuticals Inc117.96-18385.19%
GMABGenmab140.29-21845.78%
TLXTelix Pharmaceuticals Ltd162.15-25234.51%
CORTCorcept Therapeutics Inc212.86-33093.99%